|Year : 2019 | Volume
| Issue : 2 | Page : 122-130
Research progress on the intervening effects of active components of Chinese herbs on amyloid-beta-induced injury of neural cells
Hang-Xuan Wu1, Er-Wei Hao2, Zheng-Cai Du2, Jian-Feng Qin2, Wei Wei2, Xiang-Long Pan2, Jin-Ling Xie2, Xiao-Tao Hou1, Jia-Gang Deng2
1 Guangxi Key Laboratory of Efficacy Study on Chinese MateriaMedica; Guangxi Collaborative Innovation Center for Research on Functional Ingredients of Agricultural Residues; Faculty of Pharmacy, Guangxi University of Chinese Medicine, Nanning, Guangxi, China
2 Guangxi Key Laboratory of Efficacy Study on Chinese MateriaMedica, Guangxi University of Chinese Medicine; Guangxi Collaborative Innovation Center for Research on Functional Ingredients of Agricultural Residues, Nanning, Guangxi, China
|Date of Submission||15-Jun-2018|
|Date of Acceptance||01-Feb-2019|
|Date of Web Publication||20-Jun-2019|
Guangxi Key Laboratory of Efficacy Study on Chinese MateriaMedica, Guangxi University of Chinese Medicine, Nanning, Guangxi
Guangxi Key Laboratory of Efficacy Study on Chinese MateriaMedica, Guangxi University of Chinese Medicine, Nanning, Guangxi
Source of Support: None, Conflict of Interest: None
Alzheimer's disease is a common clinical central nervous system degenerative disease. From 1906, it has not yet been clearly revealed the pathogenesis, and there are no clinically safe and effective drugs. Amyloid-beta (Aβ) cascade reaction theory is currently recognized as the pathogenesis. Aβ deposition of neurotoxicity is an important part of the pathogenesis. There are Aβ-induced inflammation of the central nervous and oxidative stress-induced apoptosis induced by a variety of ways leading to neuronal dysfunction and death. This article summarizes the active ingredients of traditional Chinese medicine that has a protective effect on Aβ toxicity in recent years. Traditional Chinese medicine mainly through the antiapoptosis, antioxidation, and anti-inflammatory reduces Aβ production and deposition of Aβ on the protection of nerve cell injury.
Keywords: Alzheimer's disease, amyloid-beta cascade reaction, monomer composition, traditional Chinese medicine, β-amyloid
|How to cite this article:|
Wu HX, Hao EW, Du ZC, Qin JF, Wei W, Pan XL, Xie JL, Hou XT, Deng JG. Research progress on the intervening effects of active components of Chinese herbs on amyloid-beta-induced injury of neural cells. World J Tradit Chin Med 2019;5:122-30
|How to cite this URL:|
Wu HX, Hao EW, Du ZC, Qin JF, Wei W, Pan XL, Xie JL, Hou XT, Deng JG. Research progress on the intervening effects of active components of Chinese herbs on amyloid-beta-induced injury of neural cells. World J Tradit Chin Med [serial online] 2019 [cited 2019 Jul 19];5:122-30. Available from: http://www.wjtcm.net/text.asp?2019/5/2/122/257411
| Introduction|| |
Alzheimer's disease (AD) is a common clinical central nervous system (CNS) degenerative disease. Clinical symptoms manifested as progressive cognitive impairment, memory loss, decreased ability to daily life, and personality changes. The pathological features mainly include the senile plaque formed by the deposition of neuronal extracellular β-amyloid and abnormal phosphorylation of intracellular tau forming Neurofibrillary tangles, Neuronal apoptosis or loss, Synaptic loss, etc. The pathogenesis of Alzheimer's disease are age theory, cholinergic theory, tau protein theory, Aβ cascade theory, and many other ideas., It is currently recognized that extracellular Aβ deposition of neurons is the main pathogenic factor. Aβ destroys Ca2+ homeostasis, damages mitochondria, promotes cytochrome C release, increases Aβ aggregation, and induces apoptosis. Ca2+ also activates calcium/calmodulin-dependent protein kinase II, which leads to phosphorylation of tau protein, which produces tau protein toxicity, which ultimately leads to NETs. Aβ destroys the cholinergic nervous system by reducing ACh synthesis, inhibiting the release of neuroendogenous ACh, and Ca2+ homeostasis leading to abnormal AChE expression. Aβ can directly stimulate microglia, and activated microglia produce inflammatory factors and neurotoxic molecules, causing neuroinflammation. Aβ acts as a free radical donor or induces the production of oxygen-free radicals or activates microglia to produce oxygen-free radicals and the like to exacerbate oxidative stress. Aβ causes apoptosis, causes NFTs, destroys the cholinergic nervous system, causes neuroinflammation and oxidative stress, and causes neuronal abnormalities and death. In this paper, the active ingredients of traditional Chinese medicines that have protective effects against Aβ-induced damage are reviewed. They mainly protect Aβ from neuronal damage by reducing Aβ production and deposition and antiapoptosis, maintaining Ca2+ homeostasis, reducing oxidative stress production, and reducing the release of neuroinflammatory factors.
| Glycosides|| |
2, 3, 5, 4'-tetrahydroxy-stilbene-2-glycoside
2, 3, 5, 4'-tetrahydroxy-stilbene-2-glycoside (TSG) is one of the main symbolic ingredients of Polygonum multiflorum. Studies have shown that TSG has a significant protective effect on nerve cell injury in both AD cell models induced by Aβ25-35 and H2O2, in a time- and dose-dependent manner. In recent years, Wen-Wen et al. observed the effects of different concentrations of TSG on the growth, proliferation, and self-renewal capacity of Aβ25-35-injured neural stem cells (NSCs). The results confirmed that all doses of stilbene glycosides can reduce Aβ25-35 on NSC damage. Performance is to improve cell growth status and to increase cell proliferation rate, cell viability, and NSC counting. Zhang used two groups Aβ25-31 vitro of that induced NSCs injury AD cell models: neuronal cell differentiation model M1 (Aβ25-31, 25 μmol/L), astrocyte differentiation model M2 (Aβ25-35, 5 μmol/L) demonstrated that high dose of stilbene glycoside promoted the differentiation of NSCs induced by Aβ25-31 into neurons and inhibited the differentiation into astrocytes.
Salidroside is the main active ingredient of Rhodiola. In recent years, scientists pay attention to gradually Rhodiola in enhancing brain function, improving memory effect. Zhenqing in Aβ1-40-induced AD animal model found that salidroside through the Aβ1-40 reduces oxidative stress injury and apoptosis of neuronal cells to achieve cell protection. The mechanism is that salidroside can reduce the formation of total reactive oxygen species (ROS) in hippocampal cells, increase the activity of superoxide dismutase (SOD), decrease the content of malondialdehyde (MDA) in serum and hippocampal cells, and improve the antioxidative stress ability of model rats. Second, salidroside inhibited the transcription of gp9lphox and other subunits in the hippocampal cells of rat hippocampus. The messenger RNA (mRNA) expression, protein expression, and subunit activation were inhibited, and the NADPH oxidase-ROS signaling pathway was inhibited. Salidroside inhibits the activation of ROS-P53-mitochondrial pathway in hippocampal cells of model rats and inhibits Aβ1-40-mediated apoptosis of neural cells.
At the same time, it was foundin vitro that salidroside could reverse the decreased cell viability of Aβ1-40 by studying SH-SY5Y cell model induced by Aβ1-40. Salidroside can activate PI3K/Akt pathway to promote the nuclear translocation of Nrf2 and inhibit the expression of HO-1 induced by P53 into the nucleus, thereby preventing the antiapoptotic effect of antioxidant stress and preventing the damage of nerve cells induced by Aβ1-40.
Astragaloside (ATS) is extracted from Astragalus traditional Chinese medicine effective part of the group. Studies have shown that total glucosides of Astragalus membranaceus has anti-inflammatory, immune regulation and prevention of focal cerebral ischemia and global cerebral ischemia-reperfusion-induced brain damage, and can significantly improve D-galactose-aging mice and dexamethasone caused premature (20 months) aging model mice of learning and memory function, improving the learning and memory function of mice with reduced cyclophosphamide. Weizu study found that ATSs on glucocorticoid, glucocorticoid Aβ-induced learning and memory dysfunction, and neuronal and PC12 cell damage have some improvements. Its mechanism may be related to inhibiting the expression of APP, decreasing the production of Aβ, decreasing the neurotoxicity of glucocorticoid and Aβ, and inhibiting the apoptosis of neurons. Yan observed Astragalus main active ingredient of total glucosides of astragalus and ATS induced by intracerebroventricular injection of Aβ to improve the learning and memory ability and oxidative stress. He also found that it can improve Aβ-induced learning and memory dysfunction, reduce neuronal damage in the hippocampal tissue, increase the activity of antioxidant enzymes in the hippocampus, and decrease the content of MDA in the hippocampus. Total glucosides of astragalus and ATS can protect the neuron against injury induced by Aβ by inhibiting the production of oxidative products and decreasing the expression of inducible nitric oxide synthase (iNOS) mRNA in PC12 cells induced by Aβ.
Nuezhenoside extracted from the Ligustrum lucidum belongs to iridoids. Yue et al.,, used Aβ1-42 in human neuroblastoma cells (SH-SY5Y cells) to establish a stable AD model and found that nuezhenoside can effectively protect Aβ1-42-induced AD model and improve cell survival rate. The possible mechanism is that the nuezhenoside increases the clearance of Aβ1-42 in AD model cells, decreases the neurotoxicity caused by the deposition of extracellular Aβ, and inhibits the autophagy to achieve the protection of cells. Nuezhenoside may also inhibit the activation of nuclear factor-kappa B (NF-κB) and increase the expression of antiapoptotic factor Bcl2 protein, inhibit the apoptosis of neurons, and play a neuroprotective role.
| Phenylpropanoids|| |
Forsythiaside A, the main active ingredient of Forsythia suspensa, has pharmacological effects such as anti-inflammatory, antibacterial, and antioxidation. Forsythiaside A is gaining more and more attention for the potential of improving and treating CNS diseases, including mental diseases and neurodegenerative diseases. It has been reported in the literature, that forsythiaside A has an effect of improving learning and memory impairment in AD animal models induced by Aβ, It may inhibit the inflammatory response in the brain, Regulate the cholinergic system, Antioxidant effect and Clearing brain amyloid deposits and other related. Lin Lixia induced Aβ25-35 to induce mouse hippocampal neuronal cell line HT22 cells, to investigate the protective effect of forsythiaside A on Aβ25-35 injured neurons. The results showed that forsythiaside group A increased cell survival rate, improved cell morphology, and inhibited the release of NO, indicating that forsythiaside A can play a neuroprotective role in inhibiting neuronal damage caused by Aβ25-35.
Sodium ferulate (SF) is an effective monomer component of Chinese angelica, which has the pharmacological effects of reducing the inflammatory reaction caused by oxidative stress, resisting apoptosis, and improving the local blood supply.,
Jin established a rat model of AD by intracerebroventricular injection of aggregated Aβ25-35, It was found that sodium ferulate can inhibit the expression of inflammatory cytokines IL-1β and TNFα induced by Aβ25-35, Inhibition of iNOS and COX-2 expression increased, reducing the degree of hippocampal pyramidal neuron damages. SF also inhibits Aβ25-35-induced increase of c-Jun-terminal kinase (JNK) and p38SMAPK and upregulates phosphorylation of Akt/PKB and EKR1/2, thereby inhibiting caspase-3 activation induced by Aβ25-35.
In a model in which Aβ25-35 stimulates macrophage-induced neuronal apoptosis, SF suppresses Aβ25-35-induced increases in tumor necrosis factor α (TNFα) and nitric oxide (NO) production and inhibits Aβ25-35-induced increases in ERK1/2 and p38SMAPK expression. It was confirmed that sodium ferulate has a significant effect against the Aβ25-35-stimulated macrophage leading to the PI3K/Akt/p70S6K signal transduction pathway.
Liu studied the protective effect of sodium ferulate on hippocampal neuronal injury induced by Aβ1-42 activated cultured astrocytes. After pretreatment with SF for 6 h, the treated Aβ1-42 was treated for 24 h, and the astrocyte-conditioned medium (ACM) was added to the cultured hippocampal neurons 48 h. It was found that sodium ferulate pretreatment can significantly increase the production of IL-1β, TNF-α and NO in astrocytes induced by Aβ1-42 and synaptophysin decreases after hippocampal neuronal cells are added to ACM, LDH leakage increases. These changes increase the expression of phosphorylated caspase-3 protein. It is concluded that SF suppresses hippocampal neuronal damage caused by Aβ1-42 by inhibiting the release of astrocyte inflammatory cytokines.
Morinda officinalis is one of the four famous southern medicines, and the main component is sugar. Bajijiasu is a kind of glycoside monomer extracted from medicinal plants of M. officinalis and has the effect of inhibiting apoptosis induced by Aβ cell injury model. Its mechanism of action for the inhibition of cell injury by bajijiasu inhibits intracellular Ca2+. Increasing the mitochondrial membrane potential can increase the cellular antioxidant capacity, inhibit the activation of proapoptotic factors such as NF-κB and JAK2/STKT5, block the caspase-3 cell apoptosis cascade, and play an antiapoptotic effect. At the same time, it can activate the expression of p21, inhibit the expression of CDK4, E2F1, and other cycle regulatory proteins, correct the cell cycle disorders, and normalize the differentiation of cells to achieve the antiapoptotic effect.
Yue confirmed that bajijiasu significantly downregulated Aβ1-42 content of conditioned medium, indicating that bajijiasu can effectively increase SH-SY5Y cells' Aβ1-42-scavenging effect. And added intracellular Aβ1-42 content, indicating bajijiasu can increase the endocytosis of SH-SY5Y cells. The mechanism may be due to increased cellular LRP1 protein expression to increase cellular endocytosis of Aβ1-42.
Ginkgolide B is a monomer component extracted from Ginkgo biloba leaf and promotes neuron growth in normal hippocampal neurons. Ginkgolide B can inhibit the toxicity of Aβ but also can inhibit the extracellular LDH levels, reduce cytotoxic damage, protect the hippocampal neurons, and stabilize the cell membrane. Ginkgolide B can protect the hippocampal neurons by inhibiting the activation of caspase-3 protease and decreasing the content of extracellular K+, thereby preventing apoptosis of hippocampal neurons, reducing the damage of hippocampal neurons. Ginkgolide B and G. biloba extract had similar neuroprotective mechanisms, both of which could upregulate the expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), whereas ginkgolide B had anti-Aβ25-35 on damaged hippocampal neuron-induced apoptosis. This neuroprotective mechanism of ginkgolide B regulates the microenvironment of nerve regeneration by upregulating the expression of brain-derived neurotrophic factor and nerve growth factor genes and proteins.
Proanthocyanidins (PCs) are typically grape seed extract or French Coast pine bark extract. Pretreatment with PCs inhibited the release of NO, TNF-α, IL-1β, and IL-6 in the microglial cell supernatant of LPS-stimulated mice. The inhibitory effect was dose dependent. Proanthocyanidins have protection an inflammatory response induced by LPS-induced microglia. Zhou Yapan induced human neuroblastoma SH-SY5Y cells with Aβ25-35, it was confirmed that proanthocyanidins can inhibit the secretion of Aβ1-42, promote soluble amyloid precursor protein (sAPPα) secretion and reduce the Aβ load of neurons. At the same time, neuroprotection can reduce MDA production, increase SOD activity, improve cell antioxidant capacity, and improve cell viability.
| Flavonoids|| |
Liquiritin (LQ) is one of the main active ingredients of licorice. Yang used Aβ25-35 to damage rat primary hippocampal neurons as an AD model, it was found that liquiritin effectively attenuated Aβ25-35-induced neuronal apoptosis, at the same time, the increase in Ca2+ concentration caused by Aβ25-35 can be reduced. LQ can induce NSCs to differentiate into cholinergic neurons in vitro. LQ can both protect the primary hippocampal neurons induced by Aβ25-35 and promote axonal growth.
Baicalin (BCL) is a flavonoid extracted and isolated from Scutellaria baicalensis and has a strong function of scavenging oxygen-free radicals. Xiao-Yan et al. used low, medium, and high concentrations of BCL (25, 50, and 100 mg/mL) preconditioning 2-h neonatal rat primary hippocampal neurons and the AD model was induced by Aβ25-35 damage. Experiment found, Baicalin increased the cell viability in the Aβ25-35 injury model in a concentration-dependent manner, reduce the amount of MDA in the cell culture medium, inhibit the release of LDH, decreased β-secretase activity in Aβ25-35 injured cells.
Theaflavin and epigallocatechin gallate
Epigallocatechin gallate (EGCG) and theaflavins (TFs), respectively, are the main functional components in green and black teas. TFs in black tea are generally expressed in the form of TF, theaflavin-3-gallate, theaflavin-3'-gallate (TF-3'-G), and theaflavin-3,3'-digallate, which were the main components. TFs in black tea usually do not exceed 2%. Jing et al. incubated Aβ1-42 with EGCG and four kinds of TF monomers and detected the formation of β-sheet structure with thioflavin T fluorescence. The results showed that both EGCG and TFs could significantly reduce the β-sheet structure and inhibit Aβ1-42 aggregation. Using Aβ1-42 to induce SH-SY5Y cell injury in human neuroblastoma cells, EGCG and TF showed that EGCG and TFs could inhibit the decrease of viability and oxidative damage induced by Aβ1-42 in SH-SY5Y cells. Accelerated aging model mice (SAMP8) were treated with EGCG or TFs to find that both Aβ1-42 and advanced glycation end-products were reduced in the SAMP8 mouse serum. It was confirmed that EGCG and TFs can inhibit the neuro-oxidative damage caused by Aβ1-42.
| Terpenes|| |
Celastrol is a triterpenoid, which is the first time that Chinese scientists have extracted from Chinese medicine Tripterygium wilfordii. Cao used condensed Aβ1-42 on SH-SY5Y cells, an AD cell model for abnormal phosphorylation of Tau protein was established. Tripterine inhibited Aβ1-42-induced activation of NF-κB, and NF-κB inhibitor BAY11-7082 significantly decreased the abnormal phosphorylation of tau induced by Aβ1-42. This suggests that tripterine reduces Aβ1-42-induced abnormal phosphorylation of tau which may be related to its inhibition of NF-κB activation. Tripterine inhibits toll-like receptor 4 (TLR4) activity. It is speculated that tripterine may reduce toll dysphosphorylation induced by Aβ1-42 by decreasing TLR4 activity and inhibiting TLR4/NF-κB signaling pathway.
Tanshinone II A (Tan II A), the active ingredient extracted from Chinese traditional medicine Salvia miltiorrhiza, has the pharmacological activity of S. miltiorrhiza and is the active ingredient with the highest content in S. miltiorrhiza. Zhou and other Aβ1-42 induced hippocampal brain tissue to establish a brain slice model of AD. Using TAN II A at different dosage levels, we found that the neurons in Aβ1-42-treated hippocampal slices were damaged and their number was decreased. The expression of both GFAP and CD11b proteins in tissues increased. Each Tan II A drug intervention group alleviated neuronal damage in the hippocampal slices and decreased the expression of GFAP- and CD11b-positive cells in varying degrees. The expression of GFAP and CD11b in the tissue showed a decreasing trend, suggesting that TAN II A may inhibit the activation of AS and MG, reduce the glial cells produced by inflammatory cytokines, reduce neuronal damage, and reduce apoptosis, thereby protecting the nerves Yuan and slowing down the process of AD.
| Saponins|| |
Ginsenosides Rb1, Rd, Re, Rg1, Rg2
Li-Yun et al., established Aβ injury SK-N-SH cell model to prove that ginsenosides Rb1 and Re can reduce Aβ-induced cellular oxidative stress. Ginsenosides Rb1 and Re can inhibit threonine phosphorylation at position 216 of GSK-3β and phosphorylation of serine at position 396 of tau, suggesting that ginsenosides Rb1 and Re may inhibit tau hyperphosphorylation by inhibiting GSK-3β activity to play a neuronal protective effect.
Ling-Ling et al., constructed neuroblastoma cells (sweAPP-SK cells) highly expressing the Swedish mutant amyloid precursor protein as an AD cell model. The results showed that both ginsenoside Rb1 and ginsenoside Rg3 could effectively decrease the levels of Aβ40 and Aβ42, ROS, and Ca2+ in sweAPP-SK cells. Ginsenoside Rb1 and ginsenoside Rg3 could be inhibited by inhibiting the gene expression of proapoptotic protein apoptosis.
Peng damaged PC12 cells with Aβ25-35, it was found that ginsenoside Rb1 can increase the survival rate of model cells. Ginsenosides protect cells from Aβ-induced cell synaptic damage. Ginsenoside Rb1 inhibits ROS production and plasma membrane oxidation induced by Aβ to a certain extent, alleviates cell membrane structure and cytoskeleton damage caused by Aβ, and prevents the increase of cholesterol level caused by Aβ to protect cells. Ginsenoside Rb1 activates PPARγ molecules. Ginsenoside Rb1 activates PPARγ as an agonist to lower cholesterol level and prevents Aβ from accumulating on the surface of cell membrane, thus protecting PC12 cells.
Xia found that ginsenoside Rb1 can improve the cognitive ability of hippocampal neurons by increasing the activity of SOD and GSH-Px, decreasing the content of MDA, and increasing the antioxidant capacity of hippocampal neurons in Aβ model rats. Ginsenoside Rb1 upregulates the expression of Bcl-2; downregulates the expression of Bax, the balance ratio of Bax/Bcl-2, and the expression of caspase-3 and apoptosis; and plays a protective effect on neurons. Ginsenoside Rb1 can also exert cytoprotective effect by inhibiting Aβ-induced ROS production, downregulating Aβ-induced phosphorylation of P-ERK and P-P38 protein, and decreasing Aβ-induced apoptosis.
Li applied ginsenoside Rb1 to nerve cells in the differentiation of APP transgenic mice, Ginsenoside Rb1 can significantly reduce Tau protein hyperphosphorylation. Its mechanism of action may be: directly promotes neuronal activity and attenuates Tau protein hyperphosphorylation. Tau protein hyperphosphorylation is indirectly affected by up-regulating the activity of the upstream action factor of Tau protein.
Ling used Aβ25-35-induced cortical neurons and found that different concentrations of ginsenoside Rd intervention significantly increased Aβ25-35-induced decline in cortical neurons' PP-2A activity, suggesting that ginsenoside Rd can enhance dephosphorylation. Liu found that Aβ25-35 intervention in primary cultured hippocampal neurons can disintegrate neurons a lot, increase apoptosis, Increase the peroxidation reaction product, Reduces antioxidant enzyme activity and up-regulates mitochondrial Cyt-c expression levels, Down-regulation of Bcl2 expression levels, up-regulation of Bax expression levels. Giving ginsenoside Rd early can reduce neuronal damage and inhibit cell apoptosis. Reduce the production of peroxidation products and increase the activity of antioxidant enzymes, Upregulate Bcl2 at the mRNA level, down-regulate Bax, down-regulate Cyt-c, Ginsenoside Rd may produce neuroprotective effects by inhibiting oxidative stress.
Ginsenoside Rg1 has anti-Aβ25-35-induced primary cultured cortical neuron injury. This effect is related to the selective activation of estrogen receptor-alpha (ERα) and GR, and its downstream molecular mechanisms include upregulation of ERK phosphorylation, inhibition of NF-κB activation, and reduction of protein definitively damaging and blocking the mitochondrial apoptotic pathway. It was demonstrated that ginsenoside Rg1 not only protects against cell damage and apoptosis induced by Aβ25-35 but also protects the neurodegenerative function of the gallbladder.,
Both ginsenoside Rg1 and estrogen can ameliorate the neuronal toxicity of Aβ25-35. Both ginsenosides and estrogen can increase the expression of Bcl-2 mRNA and protein and decrease the mRNA and protein level of proapoptotic factor Bax. The upregulation of Bax/Bcl2 ratio resulted in the decrease of caspase-3 mRNA and active caspase-3 protein expression. Ginsenoside Rg1 could protect cells by antineuronal apoptosis. The neuroprotective effect of ginsenoside Rg1 may be due to its estrogen-like effect, and this effect is mainly achieved by ERβ rather than ERα.,
Tianwen demonstrated that ginsenoside Rg1 attenuated oligomeric Aβ1-42-mediated neuronal stress and protected mitochondria from neuronal apoptosis. Ginsenoside Rg also attenuated the effect of Aβ1-42 on protein kinase A (PKA)-CREB inhibition of signaling pathways that may help to improve memory function.
Notoginseng saponin is the main active ingredient of Panax notoginseng. Notoginsenoside has a wide range of effects and is mainly used in cardiovascular and cerebrovascular diseases and diseases such as immunity, dementia, and tumors. Li used a D-gal-induced subacute aging plus Aβ1-40 side ventricle directional injection to prepare a composite experimental animal model of AD. Continuous stomach administration of Panax notoginseng saponins for 8 weeks, Panax notoginseng saponins can improve the learning and memory function of the composite experimental AD animal model. P. notoginseng saponins can increase the content of antioxidants in rat brain, decrease the level of ROS in brain, inhibit the activity of caspase-3, inhibit the apoptosis of neurons, and improve the learning and memory ability of model rats. Wensheng et al. found that notoginsenoside Rl can inhibit Aβ neurotoxicity. Panax notoginseng saponin R1 compares human neuroblastoma SH-SY5Y cells induced by Aβ with model group cells, The early apoptosis rate of cells decreased after treatment with notoginsenoside R1. The increase in intracellular Ca2+ concentration is reduced, and the increase in oxygen free radicals (ROS) is reduced.
Gypenoside is the main active ingredient of Gynostemma pentaphyllum, which has many pharmacological effects such as lowering blood fat and antitumor and protecting the liver. Some scholars in AD animal models confirmed that gypenosides can significantly improve the plasma and brain tissue of senile mice SOD and GSH-Px activity, reduce the MDA content, and have a good dose–response relationship. Gynostemma saponin high, medium, and low doses of intragastric administration of mice can reduce the loss of hippocampal cells in mice brain tissue and reduce the brain cells in the hippocampus nerve densities. Gynostemma total saponins have anti-aging effects on mouse brain tissue. The n-butanol fraction of G. pentaphyllum may reduce the binding of Aβ to p75NTR, inhibit the JNK pathway, and decrease the content of pJNK, thereby inhibiting the expression of p53, enhancing the downstream Bcl2/Bax expression, decreasing the release of cytochrome C, and decreasing the release of caspase-3, and play a role in anti-senile dementia.
In the Aβ-induced AD cell model, Yanli et al. found that gypenosides can promote the growth of cholinergic neurons and their protrusions can increase neuronal activity and ChAT expression and inhibition of Aβ1-42-induced neuronal iNOS expression and apoptosis. Lixia et al. found that gypenosides can increase the survival rate of normal PC12 cells and it is effective against the decrease in cell viability caused by β-amyloid and the increase in lactate dehydrogenase content in the cytosol. Possible mechanism is that gypenosides have antioxidative activity, eliminate certain free radicals in cells, reduce the accumulation of ROS, dilate blood vessels, improve cerebral blood flow, and improve cell viability of neurons.
Kele found that Polygala tenuifolia saponin protects nerve cells by ameliorating the neurotoxic effects of Aβ and neuronal damage. Polygala tenuifolia saponin may protect nerve cells and prevent apoptosis by inhibiting the expression of Bax and promoting the expression of Bcl2 to prevent the leakage of Cyt-C to the cytoplasm, thereby inhibiting the activation of caspase cascade. Polygala tenuifolia saponin may be through the release of Aβ1-42 caused by the inhibition of protein phosphatase PP-2A, reduce protein kinase PKA expression, reduce the total neuronal total tau protein expression, and restore normal levels of tau phosphorylation.
Qinglin, found that Polygalaceae may inhibit apoptosis by reducing the expression of Bax, Bcl2, Cyt-c, and other apoptotic proteins and reduce the damage of Aβ1-42 to cells. Polygala tenuifolia saponin can reduce the content of tau protein and increase the expression of tubulin, indicating that it can alleviate protein overphosphorylation and protect neuronal cytoskeleton system. Polygala tenuifolia saponin increased the M1 receptor, ChAT expression, and synaptophysin density in PC12 cells damaged by Aβ1-42, indicating that it can improve the cholinergic system in damaged neurons.
| Alkaloids|| |
Natural medicine berberine is an isoquinoline alkaloid, which presents in the Berberidaceae, Ranunculaceae, and other families of many plants, and is the main ingredient of Chinese medicine coptis. It is also known as berberine. Li-Yun et al. found that Aβ25-35 significantly upregulated the expression of IL-1β and MCP-1 in primary glial cells and murine microglial cells. Pretreatment with 1–5-μM berberine could inhibit IL-1β and MCP-1 expression. Berberine preconditioning reduced the expression of iNOS and COX-2 in Aβ25-35-upregulated cells and primary glial cells. Berberine also inhibited NF-κB p65 nuclear translocation and NF-κB DNA-binding activity in murine BV2 microglial cells, indicating that berberine can inhibit the activation of NF-κB by Aβ25-35. Berberine anti-Aβ25-35-induced microglial inflammation may be through blocking the PI3K/Akt and MAPK pathways.
| Phenolic Acids|| |
Protocatechuic acid (PCA) is a natural phenolic compound, which is an effective active ingredient of Chinese traditional medicine. It has been found that PCA has a good antioxidant effect on ischemic-hypoxic neuron-protective effect.,
Dai using highly differentiated PC12 cells induced by Aβ1-42. PCA was found to help improve Aβ1-42-induced PC12 cytotoxicity. PCA increases Beclin-1 expression levels. PCA-protective effect may be related to increased levels of autophagy. Li induced oligomerization of Aβ1-42 to induce fetal rat hippocampal neurons, It was found that protocatechuic acid intervention increased ERK protein expression. PCA was found to protect the hippocampal neurons induced by Aβ1-42 and its mechanism was related to ERK signal transduction pathway.
Salvianolic acid B
Salvianolic acid B is a water-soluble monomer compound derived from S. miltiorrhiza, the basic structure of which is Danshensu (3,4-dihydroxybenzene lactic acid). Salvianolic acid B has a protective effect on Aβ-induced PC12 cells and primary cultured rat cortical neurons. The mechanism may be inhibition of Aβ aggregation and fibrosis, which in turn inhibits Aβ-induced cytotoxicity. Second, salvianolic acid B inhibits Aβ-induced elevation of intracellular Ca2+ and mitochondrial free radicals. Possible mechanism is to inhibit Aβ-induced Par-4 expression and intracellular Ca2+ changes.
| Summary|| |
Alzheimer's disease, Alzheimer's first case, was found over a hundred years since 1906. No safe and effective drug has been developed yet, suggesting the complexity of the pathological process. The traditional Chinese medicine compound has the advantages of multicomponent, multichannel, and multitarget. Some traditional Chinese medicine compound preparations have made some progress in clinical practice. Traditional Chinese medicine monomers can make the target more specific and the action specific. [Table 1] summarizes the mechanisms and targets of the active constituents of traditional Chinese medicine to interfere with Aβ-induced neuronal injury. Combination therapy has become an effective way of treatment.
|Table 1: Mechanism and target of active constituents of traditional Chinese medicine to interfere with amyloid-beta-induced neuronal injury|
Click here to view
Financial support and sponsorship
This work was supported by Guangxi Science and Technology Plan Project (GKH1347004-16, 15-140-31,17-259-20, GKG1355004-11).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Jia JP. Neurology. Beijing: People's Medical Publishing House; 2008. p. 214.
Hamley IW. The amyloid beta peptide: A chemist's perspective. Role in Alzheimer's and fibrillization. Chem Rev 2012;112:5147-92.
Bellucci A, Luccarini I, Scali C, Prosperi C, Giovannini MG, Pepeu G, et al.
Cholinergic dysfunction, neuronal damage and axonal loss in tgCRND8 mice. Neurobiol Dis 2006;23:260-72.
Tam JH, Pasternak SH. Amyloid and Alzheimer's disease: Inside and out. Can J Neurol Sci 2012;39:286-98.
Zhang L, Li L, Li YL. Mechanism of the protection of stilbene glycoside which is the effective component of tuber fleece flower root on nerve cells. Chin J Clin Rehabil 2004;8:118-20.
Han WW, Zhang YL, Zhou Z, Huang JH, Zhang LL. Protective effects of stilbene glycoside on Aβ25-35-induced neural stem cell injury. Chin J Exp Tradit Med Formul 2013;19:160-3.
Zhang YL, Zhou Z, Han W, Song WS, Huang JH, Zhang LL. Effects of stilbene glycoside, an active constituent of Polygonum multiflorum, on the differentiation of neural stem cells induced by Aβ25-31. J Tradit Chin Med 2014;55:323-7.
Zhang ZQ. Intervention and Mechanism of Salidroside on Alzheimer's Disease Models Induced by β-Amyloid. Shijiazhuang: Hebei Medical University; 2014.
Yao YY. Protective Effects of Astragalosides against Synergistic Hippocampal Neurotoxicity of Amyloid β-Protein and Glucocorticoids in Rats. Hefei: Anhui Medical University; 2008.
Li WZ. Protective Effects of Astragalosides against Synergistic Neuron Injury Induced by Glucocorticoids and Aβ and Its Mechanism. Hefei: Anhui Medical University; 2010.
Yan Y. Protective Effect and its Oxidation Mechanisms of the Main Components of Astragalus on Aβ25-35-Induced Alzheimer's Disease Rat Model. Wuhan: Wuhan University; 2016.
Zhang Y, Chen HF, Zheng N, Li XG, Li QQ, Zhu CX, et al
. Effects of flavonoids on apoptosis of Aβ42-induced neuronal cells and changes of related proteins NF-κB and Bcl-2. Tradit Chin Drug Res Clin Pharmacol 2016;27:215-9.
Zhang Y, Li L, Li XG, Chen HF, Luo S, Chen YB, et al
. Protective effect of flavonoids on Aβ1-42 injured SH-SY5Y cells and its mechanism. J Jinan Univ (Nat Sci Med Ed) 2016;37:49-54.
Zhang Y. Effect and Mechanism of Bajijiasu Nuezhenoside and Icariin Having Action of Reinforcing Kidney on Alzheimer's Disease. Guangzhou: Guangzhou University of Chinese Medicine; 2016.
Wang HM. Effects of Forsythiaside on Learning and Memory in Alzheimer's Disease Model and Its Mechanism. Beijing: Chinese Academy of Medical Sciences and Peking Union Medical College; 2012.
Wang YH, Xiao PG, Liu XM. Nootropic effect of forsythiaside on a novel complex mouse model of Alzheimer disease and its mechanism. Acta Lab Anim Sci Sin 2011;19:423-7, 445.
Lin LX, Zhang LW, Du HZ. Improvement of forsythoside A on neuroinflammation induced by Aβ25-35 oligomer. J Shanxi Univ (Nat Sci Ed) 2016;39:631-8.
Liu Y, Chen W, Pei YY, Ye XT, Xiao S, Ke SY, et al
. Experimental study of sodium ferulate in the treatment of glucocorticoid osteoporosis. Chin Pharmacol Bull 2016;32:394-8.
He GY, Xie M, Gao Y, Huang JG. The role of NALP3 and NF-κB signaling pathways in oxidative stress and the intervention effect of sodium ferulate. J Sichuan Univ (Med Sci Ed) 2015;46:367-71.
Jin Y. Protective Effects and Mechanism of Sodium Ferulate against Neurotoxicity Induced by Amyloid Beta-Protein. Beijing: China Medical University Graduate School; 2006.
Liu XC, Miao YH, Zhang B, Yan EZ. Sodium ferulate inhibits the release of astrocyte inflammatory cytokines by β-amyloid 1-42. Chin J Pharmacol Clin 2014;30:35-8.
Chen DL. Study on the Effect and Pharmacological Mechanism of Bajijiasu from the Polysaccharide of Morindae Officinalis on Alzheimer's Disease. Guangzhou: Guangzhou University of Chinese Medicine; 2012.
Xiao Q. Investigate Neuroprotective Effect and Mechanism of Ginkgolide B Protects Fetal Hippocampal Neurons. Xi'an: Fourth Military Medical University; 2011.
Chen JZ, Zhang XQ, Qu ZH, Zhou YP, Zhang W, Liang XY. Effects of proanthocyanidins on the secretion of inflammatory mediators of BV2 microglia induced by lipopolysaccharide. Carcinog Teratog Mutagen 2016;28:214-7.
Zhou YP, Zhang XQ, Qu ZH, Zhang W, Liang XY. Effects of proanthocyanidins on the cytotoxicity of SH-SY5Y induced by amyloid Aβ25-35. Carcinog Teratog Mutagen 2017;29:91-5.
Yang Y, Bian GX, Lu QJ. Protective and nutritive effects of glycyrrhizin on primary cultured hippocampal neurons. China J Chin Mater Med 2008;33:931-5.
Cui XY, Zhen XL, Liu XL. Protective effects of baicalin on the amyloid β-protein 25-35-impaired hippocampal nerve cell in neonatal rats. Chin J Clin Pharmacol 2016;32:1985-8.
Zhang J, Huang JA, Cai SZ, Yi XQ, Liu JJ, Wang YZ, et al
. Theaflavin and EGCG inhibit the level of β-amyloid 1-42 in vitro
and in vivo
and its induced oxidative damage of nerve cells. J Tea Sci 2016;36:655-62.
Cao FF, Xu LM, Wang Y, Peng B, Zhang X, Zhang DH. Effect of tripterine on the abnormal phosphorylation of Tau protein induced by amyloid beta in SH-SY5Y cell. J Tongji Univ (Med Ed) 2016;37:36-9, 50.
Zhu B, Zhai Q, Yu B. Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition. Pharm Biol 2010;48:484-7.
Zhou L, Zhou J, Liu YP. Effect of tanshinone II A on the expressions of NeuN, GFAP and CD11b in Aβ1-42
induced newborn rat hippocampal slices in vitro
. Chine J Cell Mol Immunol 2013;29:1150-4.
Jia LY. Research on the Neuroprotective Effects of Ginsenoside and Berberine and the Underlying Mechanism. Jinan: Shandong University; 2012.
Jia LY, Pan XH, Liu J, Cui X, Wang ML. Protective effects of ginsenoside Rb1 and Re on SK -N -SH cells injured by Aβ25-35. J Shandong Univ (Health Sci) 2011;49:33-7.
Yang LL, Sun GY, Hao JR, Wei YP, Guo YF, Cui X, et al
. Study on the protective effect of ginsenoside Rb1 on SweAPP-SK cells. Chin J Gerontol 2013;33:6187-9.
Yang LL. Ginsenoside Rb1 and Ginsenoside Rg3 Inhibit the Neurotoxicity of β-Amyloid Peptide by Up-Regulating Gene Expression. Jinan: Shandong University; 2009.
Peng Y. Ginsenoside Rb1's Protective Effects on Amyloid Peptide-Induced PC12 Cell Cytotoxicity. Guangzhou: Jinan University; 2012.
Xie X. Mechanism of Protective Effect of Ginsenoside Rb1 on Amyloid-β-Peptide Induce Neuron Apoptosis. Shenyang: China Medical University; 2009.
Li GD, Yuan BMi, Pei WH, Xing Y. Intervention of ginsenoside Rb1 on Tau protein hyperphosphorylation in mouse neural cells induced by endogenous Aβ. Shandong Med J 2009;49:26-8.
Li L. Neuroprotective Effects and Mechanism of Ginsenoside Rd on Models of Alzheimer's Disease. Xi'an: Fourth Military Medical University; 2012.
Liu JF. Study of Protective Effects and Mechanisms of Ginsenoside Rd on Experimental Alzheimer's Disease. Xi'an: Fourth Military Medical University; 2011.
Wu JY. Ginsenoside Rg1 Protects Primary Cortical Neurons against Aβ25-35 Insult and Promotes Neural Differentiation of Embryonic Stem Cells Via Selective Steroid Hormone Receptor Activation Pathway. Hangzhou: Zhejiang University; 2012.
Wu JY, Shen YY, Zhu WJ, Cheng MY, Wang ZQ, Liu W, et al
. Apoptosis of primary rat cortical neurons induced by ginsenoside Rg1 via mitochondrial pathway against Aβ25-35. J Zhejiang Univ (Med Sci) 2012;414:47-55.
Gong L. Study on neuroprotective effect of Ginsenoside Rg1 in postmenopause women Alzheimer's Disease cell model and its mechanism. Jinan: Shandong University, 2010.
Zhou LP, Ge KL, Chen WF. Protection of ginsenoside Rg1 against-amyloid peptide-induced neurotoxicity in mice hippocampal neurons. Acta Acad Med Qingdao Univ 2011;47:189-91.
Huang TW. Ginsenoside Rg1 Attenuated Oligomeric Beta-Amyloid 1-42 Mediated Neurotoxicity by Inhibiting Neuronal Stress. Fuzhou: Fujian Medical University; 2007.
Li SM. Role and Mechanism of Panax
Notoginsenoside in D-Galactose Combined Aβ (1-40)-Induced Rats Models of AD. Kunming: Kunming Medical University; 2009.
Zhang WS, Chen CJ, Ma T, Qiao SM, Yuan XD, Zhou XY. Protective effects of Panax notoginseng and its active ingredients on Aβ25-35 induced SH-SY5Y cell injury. Proceedings of the 2008 National Conference on Anti-Aging and Alzheimer's Disease. Dalian: Chinese Pharmacological Society; 2008. p. 191.
Huang H. Study on the Anti-Aging Action of Gypenosides on Brain Tissue of Ged Mice Induced by D-Galactos. Jinan: Shandong Normal University; 2010.
Wu YC. To study anti-Alzheimer's Disease Effect and its Mechanism of Effective Parts of Gynostemma pentaphylla
on Rapid Aging Dementia Mice (SAMP8 mice). Guangzhou: Guangzhou University of Chinese Medicine; 2013.
Zheng YL, Sun TM, Wang M, Li RH, Yao BC, Tan HB. Effects of Gynostemma Pentaphyllum on Aβ-induced AD cell model. Chin J Integr Tradit West Med 2012;10:201-4.
Yang LX, Lu ZH, Huang JB, Zhang B. Protective effects of Gynostemma pentaphyllum on PC12 cell proliferation and cell injury model. Amino Acids Biotic Resour 2016;38:24-8.
Xu KL. The Study on the Protect of Ten on Neurons Apoptosis and Hyperphosphorylation of Tau Protein in Neurons of AD Rat Induced by Aβ1-40
. Hefei: Anhui University; 2012.
Chen QL. The Research on the Protective Effects and Mechanism of Tenugenin to the Mice and PC12 Cells Model of Alzheimer's Disease Induced by Aβ1-40
. Hefei: Anhui University; 2011.
Chen QL, Chen Q, Jin BB. Protective mechanism of Polygala
tenin to dementia model induced by Aβ1-40
in mice and PC12 Cells. Pharmacol Clin Chin Mater Med 2011;27:35-8.
Zhang X, Shi GF, Liu XZ, An LJ, Guan S. Anti-ageing effects of protocatechuic acid from alpinia on spleen and liver antioxidative system of senescent mice. Cell Biochem Funct 2011;29:342-7.
Li ZY, Xia Y, Chen XD, Luo H, Zhang HY. Protective effects of protocatechuic acid extracted from Yizhiren on focal cerebral ischemia-reperfusion injury in rats. Hainan Med J 2013;24:157-9.
Dai WW, Zhang SJ, Cai WB, Chen HF, Zheng N, Xu QQ, et al
. Protective effect and mechanism of protocatechuic acid on β-amyloid protein-1(1-42) induced PC12 cytotoxicity. J Guangzhou Univ Tradit Chin Med 2016;33:66-70.
Li ZY, Luo H, Zhang HY. Protective effect of protocatechuic acid on AD hippocampl neurons treated with Aβ1-42
oligomer. Hainan Med J 2015;26:2029-31.
Tang MK. Protective Effect of SalB on Amyloid β Peptide Induced Neural Cell Damage and its Mechanism of Action. Beijing: China Medical University; 2002.
Möller HJ, Graeber MB. The case described by Alois Alzheimer in 1911. Eur Arch Psychiatry Clin Neurosci 1998;248:111-22.
Ow SY, Dunstan DE. A brief overview of amyloids and Alzheimer's disease. Protein Sci 2014;23:1315-31.